Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am checking with some folks in CA who have large share positions
to see if they can somehow figure out how the 150 million shares
comes into play aside from the obvious. One of them is a market director. Going to get his perspective as it pertains to future events unfolding verses past realities on equity financing.
Pros & Cons.
Share your sentiments below for the moment.
There's a part of me that actually wants to give management those shares if I'm to be fully honest. All they need to do is grease that wheel a bit. So far it's dry as a bone and I'm left with a pile of uncertainty. Not a good combination for swaying ones decision with such a hefty increase in shares.
Ok you got me on this statement below. Well stated.
Like I've said, please don't shoot the messenger.
I do want PPHM to succeed.
I'm trying to bring a higher level of awareness to the problems so shareholders will force management/BOD to be accountable to them.
Obviously the current situation IS NOT working. Has not worked for many years. The last thing shareholders need is more of the same failed methods of NOT creating shareholder value.
For management to say or think that the share price will take care of itself is naive.
And it's so simple. Stop the dilution and watch the stock price go up!
I have four accounts with shares. Your POST has merit.
Bavi approval. This is the pipeline. That's it. PPS may rise on anticipation but sustained breakout does not happen until approved and licensed.
Music to the ears! EOM
Nice to see all of these combo therapy collaborations developing. More to come.
Sunstar excellent points made.
Thanks cjgaddy Good read. EOM
CP Could not agree more with statement below but understand the anger/frustration the long term holders have.
I know why I stand behind this management: They stuck their necks out and provided PPHM with IP right that are crucial. Now that everything starts to come together and we have no more creditors, own our IP and pipelines 100% unencumbered and have a SUNRISE PIII trial close to approval, now we suddenly have a problem with compensation.
Believe me a FULL 8 or 12 member Bod would cost us MUCH MORE in total.
semper You have been a positive influence on this board. I know you are frustrated to say the least but I hope you reconsider and continue to post. Sunrise Approval will be our payment. Focus on science.
CP that summarizes it all very well. Thanks.
CP If SUNRISE is going quite well and anticipation of approval on the horizon then this all makes sense. Preparation to fund all aspects of production & marketing etc. Future trials. Plus many other factors cited on this board earlier.
BIO When SUNRISE approved these discussions on dilution melt away. Until then....
Real Your on a roll with posting this morning. Thanks for briefing the board on our situation. Anything positive to share? Will take it.
Yes that time frame should yield some positive flow?
I do think we will know more in this area within the next 2-3 months.
MazelMan Approval will right the ship. In the meantime...
bigbro1 Unpopular but need to roll with this. Voting yes?
Paul With you on those thoughts. Put more in the kitty on this one then usual.
That pattern is a money maker. Maybe the PR news will stop the retrace this time around and put us in $10-15 range and adjust up from there over time.
Maybe not $5+, but I think $3.50 - $4 is more than attainable before retracing.
I like this one.
“Passionate Company, Passionate People... ”
The greater the leverage the better the deal. Simple but true.
Ask Trump.
Semper I posted this a couple days ago. But thanks again.
Interesting. In lieu of all that has developed since that trial I would respectfully disagree.
Nonsense, they have many failed trials and one botched that no one believes in.
Chris I was not aware of that. Interesting.
They have more then enough data to partner actually too much. Doubling of survival in breast and 2nd line lung and melanoma data in hand. Did PCYC or JUNO have data on over 600 patients when they partnered? Oh yah no they both only had data on phase 1/2 on less then sixty patients.
Stocks Trading Near Their 52-Week Lows: 4 Hot Picks
Zacks
By Zacks Equity Research 44 minutes ago
One of....
4 Fallen Angels to Buy Now
Peregrine Pharmaceuticals, Inc. PPHM
Tustin, CA-based biopharmaceutical company, Peregrine Pharmaceuticals researches and develops monoclonal antibodies for the treatment and diagnosis of cancer in the U.S. and internationally. Notably, the company is presently trading near its 52-week low of $1.00.
Peregrine Pharma’s lead pipeline candidate, bavituximab, is being developed for multiple oncology indications including the treatment of second-line non-small cell lung cancer (NSCLC). We believe the successful development and commercialization of bavituximab would be a major positive for Peregrine Pharma, which currently has no approved drug.
The company also boasts a solid Zacks Rank #2 and an equally impressive Growth Score of ‘B’. Moreover, the stock has been witnessing positive estimate revisions over the past one month, as the current year consensus estimate of loss has narrowed 8.6% over the same time frame.
Sorry CP am going from recollect. However, I do recall him alluding to the preferred indicating the redemption period would be around end of Sunrise trial.
SK alluded to redeeming the preferred at the end of 2016 on one of the conference calls. What I do not recall was the point of that statement. Perhaps to indicate a non conversion to common?
It is "funny" how so many things are scheduled and come together in the fall of 2016, SUNRISE, Preferred shares can be redeemed, poison pill scheduled to end.
Dr. Hutchins being appointed chairman of the Boston I/O combo conference on 8/26 is very logistical.
Porkchop11 With the efficacy of bavi it is about a better treatment combo regimen. IMO
Thanks Couch...Ex-Wannabe, what's this all about...
Couch Add Bavi to the mix a couple weeks before full treatment regimen commenced and I wander what percentage of patients would have responded then?
North Got mine. Janet cough! cough! Ble... cough! cough! Sorry having a hard time getting my name choice out so withdraw my vote
consideration.
CP Continue to drink that coffee. Thanks for thoughts to consider.
But now, with a good cup of coffee I was suddenly thinking : What is a censored patients if he were NOT censored.
Chris Thanks for your continued optimistic post. Your time lines are off but so are a lot of other folks which is to be expected. However, you have done a great job in reminding everyone of what the essence of the science means for patients and our pocket books.
I saw that and figured it was hers.
Well at least my neighbor made out, she ended up buying in @1.14 instead of 1.23
Vacations coming to and end for most folks. Just came back from St. Croix myself. Suspect will see some upward price movement soon enough. (wrong) One of my neighbors came by yesterday afternoon and mentioned she has a small buy order in for 4000 shares @1.23 this morning. Good for her.
Vacations coming to and end for most folks. Just came back from St. Croix myself. Suspect will see some upward price movement soon enough. One of my neighbors came by yesterday afternoon and mentioned she has a small buy order in for 4000 shares @1.23 this morning. Good for her.
semper Thanks for the several links provided good information. EOM
HMMM must be anticipating commercialization.
Cheynew I was looking at that last night myself. Thanks for sharing.
The glass is half full not half empty as some would suggest
Yes that survey fizzled out oh well. EOM